Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1998 1
1999 2
2004 2
2005 2
2006 1
2007 1
2009 4
2010 6
2011 4
2012 6
2013 8
2014 10
2015 14
2016 11
2017 14
2018 14
2019 17
2020 25
2021 25
2022 32
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators. Wiviott SD, et al. N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415602 Clinical Trial.
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
O'Donoghue ML, Rosenson RS, Gencer B, López JAG, Lepor NE, Baum SJ, Stout E, Gaudet D, Knusel B, Kuder JF, Ran X, Murphy SA, Wang H, Wu Y, Kassahun H, Sabatine MS; OCEAN(a)-DOSE Trial Investigators. O'Donoghue ML, et al. N Engl J Med. 2022 Nov 17;387(20):1855-1864. doi: 10.1056/NEJMoa2211023. Epub 2022 Nov 6. N Engl J Med. 2022. PMID: 36342163 Free article. Clinical Trial.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy.
Kusadasi N, Sikma M, Huisman A, Westerink J, Maas C, Schutgens R. Kusadasi N, et al. Among authors: westerink j. Hemasphere. 2020 Aug 10;4(4):e457. doi: 10.1097/HS9.0000000000000457. eCollection 2020 Aug. Hemasphere. 2020. PMID: 32885147 Free PMC article. Review.
Exploring physiologic reactions to persuasive information.
Spelt HAA, Asta L, Kersten-van Dijk ET, Ham J, IJsselsteijn WA, Westerink JHDM. Spelt HAA, et al. Among authors: westerink jhdm. Psychophysiology. 2022 Jun;59(6):e14001. doi: 10.1111/psyp.14001. Epub 2022 Jan 23. Psychophysiology. 2022. PMID: 35066870 Free PMC article.
Bempedoic acid: Everything with a place and purpose.
Westerink J. Westerink J. Eur J Prev Cardiol. 2021 Jul 23;28(8):823-824. doi: 10.1177/2047487320929779. Eur J Prev Cardiol. 2021. PMID: 33611517 Free article. No abstract available.
Diagnosing and treating antiphospholipid syndrome: a consensus paper.
Limper M, de Leeuw K, Lely AT, Westerink J, Teng YKO, Eikenboom J, Otter S, Jansen AJG, V D Ree M, Spierings J, Kruyt ND, van der Molen R, Middeldorp S, Leebeek FWG, Bijl M, Urbanus RT. Limper M, et al. Among authors: westerink j. Neth J Med. 2019 Apr;77(3):98-108. Neth J Med. 2019. PMID: 31012427 Free article.
Letter by Westerink and Visseren Regarding Article, "Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial".
Westerink J, Visseren F. Westerink J, et al. Arterioscler Thromb Vasc Biol. 2017 May;37(5):e53. doi: 10.1161/ATVBAHA.117.309295. Arterioscler Thromb Vasc Biol. 2017. PMID: 28446474 No abstract available.
Chronic kidney disease and atrial fibrillation: A dangerous combination.
Ocak G, Khairoun M, Khairoun O, Bos WJW, Fu EL, Cramer MJ, Westerink J, Verhaar MC, Visseren FL; UCC-SMART study group. Ocak G, et al. Among authors: westerink j. PLoS One. 2022 Apr 7;17(4):e0266046. doi: 10.1371/journal.pone.0266046. eCollection 2022. PLoS One. 2022. PMID: 35390012 Free PMC article.
191 results